Septerna, Inc.
SEPN
30 insider filings · Latest: Aug 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Aug 14 9:44 PM | Third Rock Ventures V, L.P.10% Owner | Sale | 147,200 | $50.27 | $7.4M | 6,068,391(D) | View → |
| Aug 12, 2026 | Aug 14 9:11 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Sale | 1,493,000 | $42.50 | $63.5M | 725,443(I) | View → |
| Aug 11, 2026 | Aug 13 11:00 PM | Elizabeth BhattPresident and COO | Sale | 25,000 | $44.00 | $1.1M | 174,209(D) | View → |
| Aug 12, 2026 | Aug 12 11:06 PM | RA Capital Healthcare Fund LP | Proposed Sale | 746,500 | $48.19 | $36.0M | — | View → |
| Aug 12, 2026 | Aug 12 10:55 PM | RA Capital Nexus Fund III, L.P. | Proposed Sale | 746,500 | $48.19 | $36.0M | — | View → |
| Aug 12, 2026 | Aug 12 8:09 PM | Third Rock Ventures V, L.P. | Proposed Sale | 147,200 | $51.00 | $7.5M | — | View → |
| Aug 11, 2026 | Aug 11 8:28 PM | ELIZABETH P. BHATT | Proposed Sale | 29,000 | $38.85 | $1.1M | — | View → |
| Aug 3, 2026 | Aug 5 11:00 PM | Daniel D. LongSVP, Drug Discovery | Sale | 3,334 | $34.47 | $114.9K | 96,412(D) | View → |
| Jul 15, 2026 | Jul 17 11:00 PM | Elizabeth BhattPresident and COO | Sale | 4,000 | $33.99 | $136.0K | 174,209(D) | View → |
| Jul 15, 2026 | Jul 15 8:23 PM | ELIZABETH P. BHATT | Proposed Sale | 4,000 | $34.54 | $138.2K | — | View → |
| Jul 1, 2026 | Jul 2 11:00 PM | Daniel D. LongSVP, Drug Discovery | Sale | 3,333 | $34.36 | $114.5K | 96,412(D) | View → |
| Jun 29, 2026 | Jun 30 11:01 PM | Samira ShaikhlyChief People Officer | Sale | 2,178 | $35.18 | $76.6K | 793(D) | View → |
| Jun 26, 2026 | Jun 26 8:02 PM | JAE KIM | Proposed Sale | 2,438 | $36.61 | $89.2K | — | View → |
| Jun 22, 2026 | Jun 24 11:24 PM | Daniel D. LongSVP, Drug Discovery | Sale | 15,000 | $35.51 | $532.6K | 96,412(D) | View → |
| Jun 22, 2026 | Jun 22 8:40 PM | DANIEL LONG | Proposed Sale | 25,000 | $36.17 | $904.3K | — | View → |
| Jun 22, 2026 | Jun 22 8:16 PM | JAE KIM | Proposed Sale | 94,339 | $35.26 | $3.3M | — | View → |
| Jun 12, 2026 | Jun 17 12:31 AM | Samira ShaikhlyChief People Officer | Sale | 6,250 | $35.08 | $219.2K | 793(D) | View → |
| Jun 12, 2026 | Jun 12 8:42 PM | SAMIRA SHAIKHLY | Proposed Sale | 8,428 | $34.03 | $286.8K | — | View → |
| Jun 1, 2026 | Jun 3 11:11 PM | Samira ShaikhlyChief People Officer | Sale | 5,935 | $28.93 | $171.7K | 793(D) | View → |
| May 26, 2026 | May 28 11:02 PM | Samira ShaikhlyChief People Officer | Sale | 11,798 | $30.06 | $354.7K | 793(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Feb 11 12:17 AM | Daniel D. LongSVP, Drug Discovery | Grant/Award | 80,000 | $25.41 | 80,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:15 AM | Uwe KleinSVP, Biological Sciences | Grant/Award | 80,000 | $25.41 | 80,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:13 AM | Samira ShaikhlyChief People Officer | Grant/Award | 80,000 | $25.41 | 80,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:10 AM | Gil M LabrucherieChief Financial Officer | Grant/Award | 125,000 | $25.41 | 125,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:08 AM | Jae B. KimChief Medical Officer | Grant/Award | 125,000 | $25.41 | 125,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:05 AM | Elizabeth BhattPresident and COO | Grant/Award | 155,000 | $25.41 | 155,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:03 AM | Jeffrey FinerDirector, Chief Executive Officer | Grant/Award | 400,000 | $25.41 | 400,000(D) | View → |
| Feb 6, 2026 | Feb 11 12:01 AM | Mark Andrew WilsonChief Legal Officer | Grant/Award | 165,000 | $25.41 | 165,000(D) | View → |
← Previous
Page 2 of 2